LAGUNA NIGUEL, Calif.--(BUSINESS WIRE)--Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that Dr. Marc H. Hedrick, President and CEO of Cytori Therapeutics, will present at the 27th Annual ROTH Conference in Laguna Niguel, California, March 8-11, 2015. Cytori’s presentation is scheduled to begin March 10th at 11:00 AM, Pacific Time, in Track 6, Salon 6.
About the ROTH Conference
The annual ROTH Conference, hosted by Roth Capital Partners, is one of the largest of its kind with over 500 participating companies and over 3000 attendees, and features presentations from hundreds of public and private companies in a variety of industries, including healthcare. The conference includes company presentations, one-on-one and small group meetings, and panel discussions.
About Cytori Therapeutics, Inc.
Cytori Therapeutics is a late stage cell therapy company developing autologous cell therapies from adipose tissue to treat a variety of medical conditions. Data from preclinical studies and clinical trials suggest that Cytori Cell Therapy™ acts principally by improving blood flow, modulating the immune system, and facilitating wound repair. As a result, Cytori Cell Therapy™ may provide benefits across multiple disease states and can be made available to the physician and patient at the point-of-care through Cytori’s proprietary technologies and products. For more information: visit www.cytori.com.